# The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity

> **NCT02992197** · PHASE4 · COMPLETED · sponsor: **University of Vermont** · enrollment: 220 (actual)

## Conditions studied

- Rotavirus Infection
- Vaccine Response Impaired
- Vaccine Virus Shedding

## Interventions

- **BIOLOGICAL:** Rotarix, dose 1
- **BIOLOGICAL:** Rotarix, dose 2
- **DRUG:** Placebo (for Rotarix dose 2)

## Key facts

- **NCT ID:** NCT02992197
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-12
- **Primary completion:** 2018-06-07
- **Final completion:** 2018-06-07
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2020-08-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992197, "The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02992197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*